Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The glaucomas in pseudophakia.

C E Traverso1, K F Tomey, E Gandolfo

  • 1Clinica Oculistica dell' Universitá, Ospedale San Martino Pad 9, Genova, Italy.

Current Opinion in Ophthalmology
|March 8, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Vivo Confocal Microscopy Characterization of Candida parapsilosis Keratitis.

Eye & contact lens·2024
Same author

Equianalgesia, opioid switch and opioid association in different clinical settings: a narrative review.

European review for medical and pharmacological sciences·2022
Same author

Aflibercept, ranibizumab and bevacizumab upcoming biosimilars: a general overview.

Drugs of today (Barcelona, Spain : 1998)·2021
Same author

Razumab -- the role of biosimilars for the treatment of retinal diseases.

Drugs of today (Barcelona, Spain : 1998)·2021
Same author

An update on ripasudil for the treatment of glaucoma and ocular hypertension.

Drugs of today (Barcelona, Spain : 1998)·2020
Same author

An update on conbercept to treat wet age-related macular degeneration.

Drugs of today (Barcelona, Spain : 1998)·2020
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Glaucoma in pseudophakia requires individualized treatment due to various causes. Surgical options like trabeculectomy, implants, and cyclodestructive procedures can be effective when medications fail.

Area of Science:

  • Ophthalmology
  • Glaucoma Research

Background:

  • Glaucoma following cataract surgery (pseudophakia) is a recognized clinical challenge.
  • The management of these glaucomas is complex due to diverse underlying mechanisms.

Purpose of the Study:

  • To review the literature on glaucoma in pseudophakia published between October 1994 and September 1995.
  • To discuss management strategies and surgical options for this condition.

Main Methods:

  • Literature review of studies published within a specific one-year period.
  • Analysis of reported surgical interventions and their outcomes.

Main Results:

  • Glaucomas in pseudophakia are often difficult to manage medically.
  • Surgical interventions including trabeculectomy with anti-metabolites, glaucoma drainage devices, and cyclodestructive procedures are viable options.

Related Experiment Videos

  • While effective, these surgeries carry risks of complications and vision loss.

    • Conclusions:

    • Individualized patient evaluation is crucial for managing glaucoma in pseudophakia.
    • Surgical interventions offer alternatives when medical management is insufficient.
    • Informed patient discussion regarding treatment efficacy and risks is essential for decision-making.